We develop allogeneic MSC-based therapies supported
by artificial intelligence to improve treatment success
across multiple regenerative applications.
A single platform. Multiple regenerative therapies.
Built on umbilical cord–derived mesenchymal
stem cells, Mestem Bio platform is designed to
scale and develop regenerative therapies across
different clinical contexts.
The Problem
Every 3 seconds, someone loses years of
functional life to a fracture. Across aging and active populations, fractures lead to chronic pain, repeated interventions, and reduced return to work. Current treatments fail to restore regenerative capacity, driving major healthcare and productivity losses and long-term loss of quality of life…
The Solution
Our technology HyaloCell-B®
We are developing a ready-to-use cell therapy for pharmaceutical partners in regenerative medicine. Our product combines umbilical cord–derived stem
cells bioactivated with hyaluronic acid to enable faster, more natural bone repair. It offers a safe, scalable, off-the-shelf alternative to invasive surgeries and grafts.
Allogeneic, off-the-shelf approach
Umbilical cord–derived mesenchymal stem cells enable standardized production and immediate availability without patient-specific manufacturing.
Scalable manufacturing
Cell production and formulation are designed with scalability and reproducibility in mind, supporting future clinical and industrial development.
Single-application therapy
Designed to deliver therapeutic effect through a single intervention, reducing procedural complexity and the need for repeat treatments.
Proprietary cell–matrix formulation
A proprietary combination of mesenchymal stem cells and hyaluronic acid developed to support cell function and therapeutic delivery.
Clinically oriented development
Technology decisions are guided by clinical feasibility, regulatory considerations, and real-world implementation from early stages.
Laura Alaniz, PhD
Co-founder, CEO & CSO
Catalina Latina, BS
Co-founder & CTO
Antonella Icardi, BS
Biomechanics Scientist
Daiana Vitale, PhD
Hyaluronic Acid Specialist
Paolo Rosales, BS
Inmunology & Biocompatibility
Franco Sviercz, PhD
Cell Therapy Scientist
Iván Mantello, BA
IA & Software Development
Gastón Chiesa, MD
Medical Advisor
Mariana García, PhD
Scientific advisor
Mariana Aulet,
GMP & CMC advisory lead
Lucía Curti
Business developer
José Ferrari, BBA
Business developer
Laura Alaniz, PhD
Co-founder, CEO & CSO
Laura Alaniz, PhD
Co-founder, CEO & CSO
Antonella Icardi, BS
Biomechanics Scientist
Daiana Vitale, PhD
Hyaluronic Acid Specialist
Paolo Rosales, BS
Inmunology & Biocompatibility
Franco Sviercz, PhD
Cell Therapy Scientist
Iván Mantello, BA
IA & Software Development
José Ferrari, BBA
Business developer
Laura Alaniz, PhD
Co-founder, CEO & CSO
Solicitar nombre
Solicitar nombre
Solicitar nombre
Solicitar nombre
Gastón Chiesa, MD
Medical Advisor
Scientific updates, biotechnology conferences, research
milestones and industry recognition from Mestem Bio.
February 11, 2026
Reconocimiento a la innovación:
Mestem bio seleccionada para
el programa WISE Women…
February 11, 2026
Reconocimiento a la innovación:
Mestem bio seleccionada para
el programa WISE Women…
February 11, 2026
Reconocimiento a la innovación:
Mestem bio seleccionada para
el programa WISE Women…
February 11, 2026
Reconocimiento a la innovación:
Mestem bio seleccionada para
el programa WISE Women…
February 11, 2026
Reconocimiento a la innovación:
Mestem bio seleccionada para
el programa WISE Women…
February 11, 2026
Reconocimiento a la innovación:
Mestem bio seleccionada para
el programa WISE Women…
Invest in the future of
regenerative therapies
Mestem bio is building a next-stage regenerative therapeutics platform based on scalable allogeneic mesenchymal stem cells and integrated predictive AI.
Our approach is designed to accelerate clinical translation, reduce development risk, and build a scalable therapeutic platform capable of addressing multiple regenerative medicine markets.
If you are interested in learning more about our project and investment opportunities, request our Investor
In Mestem Bio, we offer training and upskilling opportunities in the fields of cell and molecular biology, biotechnology, and health innovation.
Our goal is to bring scientific and technological knowledge closer to researchers, professionals, and students interested in understanding and developing new solutions in the life sciences.
Free Webinars
Short virtual sessions aimed at sharing knowledge, trends, and advances in biotechnology and health innovation. They are designed as open spaces for learning, updates, and discussion.
Virtual Mini-Courses
Short online courses focused on specific topics, including supporting materials and activities oriented toward the practical application of knowledge.
In-person / Hybrid Courses
More intensive training experiences that combine theoretical and practical content, aimed at developing applied skills in biotechnology, research, and technology transfer.